
Alexion Pharmaceuticals, Inc. ALXN
Alexion Pharmaceuticals, Inc. Cash Conversion Cycle 2011-2026 | ALXN
Annual Cash Conversion Cycle Alexion Pharmaceuticals, Inc.
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 12.8 | - | 149 | 458 | 411 | 106 | 181 | 148 | 180 | 136 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 458 | 12.8 | 198 |
Cash Conversion Cycle of other stocks in the Biotechnology industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Alector
ALEC
|
-13.8 | $ 2.08 | -14.4 % | $ 214 M | ||
|
Altimmune
ALT
|
15.1 K | $ 4.2 | -2.67 % | $ 298 M | ||
|
Apellis Pharmaceuticals
APLS
|
115 | $ 20.24 | -3.44 % | $ 2.55 B | ||
|
Aptorum Group Limited
APM
|
-400 | $ 0.8 | 1.87 % | $ 4.36 M | ||
|
Aptevo Therapeutics
APVO
|
-47.4 | $ 7.2 | -1.64 % | $ 1.99 M | ||
|
I-Mab
IMAB
|
-1.97 K | - | - | $ 866 M | ||
|
Aquestive Therapeutics
AQST
|
-15.2 | $ 4.1 | 2.37 % | $ 356 M | ||
|
AgeX Therapeutics
AGE
|
-8.96 K | - | -10.17 % | $ 12.2 K | ||
|
Arcturus Therapeutics Holdings
ARCT
|
43.2 | $ 8.35 | 1.46 % | $ 225 M | ||
|
Ardelyx
ARDX
|
885 | $ 6.37 | -2.75 % | $ 1.54 B | ||
|
Arcutis Biotherapeutics
ARQT
|
158 | $ 25.33 | -6.1 % | $ 3.22 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
17 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
82.8 | - | -18.52 % | $ 27.3 M | ||
|
Arvinas
ARVN
|
4.66 | $ 12.97 | -2.3 % | $ 920 M | ||
|
Arrowhead Pharmaceuticals
ARWR
|
8.75 | $ 61.74 | -2.42 % | $ 8.26 B | ||
|
Atossa Therapeutics
ATOS
|
-2.25 K | $ 4.39 | -0.9 % | $ 553 M | ||
|
Atara Biotherapeutics
ATRA
|
50.4 | $ 5.01 | -7.47 % | $ 37.5 M | ||
|
Aurinia Pharmaceuticals
AUPH
|
612 | $ 14.14 | -0.21 % | $ 1.9 B | ||
|
Acorda Therapeutics
ACOR
|
117 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | ||
|
Albireo Pharma
ALBO
|
-1.55 K | - | -0.23 % | $ 916 M | ||
|
Axon Enterprise
AXON
|
86.2 | $ 570.5 | 5.18 % | $ 43.2 B | ||
|
Axsome Therapeutics
AXSM
|
-256 | $ 162.28 | -0.98 % | $ 8.07 B | ||
|
Aytu BioScience
AYTU
|
174 | $ 2.56 | -0.58 % | $ 16.1 M | ||
|
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B |